Related references
Note: Only part of the references are listed.Molecular Epidemiology of Emerging Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010 to 2014
Feng-Jut Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Comparative Analysis of the Two Acinetobacter baumannii Multilocus Sequence Typing (MLST) Schemes
Stefano Gaiarsa et al.
FRONTIERS IN MICROBIOLOGY (2019)
In vitro and in vivo Virulence Potential of the Emergent Species of the Acinetobacter baumannii (Ab) Group
Clara Cosgaya et al.
FRONTIERS IN MICROBIOLOGY (2019)
Genetic Characterization of Plasmid-Borne blaOXA-58 in Distinct Acinetobacter Species
Adriana P. Matos et al.
MSPHERE (2019)
Molecular Epidemiology of Emerging blaOXA-23-Like- and blaOXA-24-Lik-Carrying Acinetobacter baumannii in Taiwan
Shu-Chen Kuo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Identification of Acinetobacter seifertii isolated from Bolivian hospitals
Monica Cerezales et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2018)
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Darren Wong et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems
Eun-Jeong Yoon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Detection of OXA-58-Producing Acinetobacter seifertii Recovered from a Black-Necked Swan at a Zoo Lake
Ana Clara Narciso et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy
Yi-Tzu Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Old Clinical Isolates of Acinetobacter seifertii in Brazil Producing OXA-58
Rodrigo Cayo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Acinetobacter dijkshoorniae sp nov., a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex mainly recovered from clinical samples in different countries
Clara Cosgaya et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2016)
Structure and context of Acinetobacter transposons carrying the oxa23 carbapenemase gene
Steven J. Nigro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
The first cases of human bacteremia caused by Acinetobacter seifertii in Japan
Kozue Kishii et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
Acinetobacter seifertii Isolated from China Genomic Sequence and Molecular Epidemiology Analyses
Yunxing Yang et al.
MEDICINE (2016)
AbaR-Type Genomic Islands in Non-baumannii Acinetobacter Species Isolates from South Korea
Dae Hun Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Acinetobacter seifertii sp nov., a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated from human clinical specimens
Alexandr Nemec et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2015)
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for species identification of Acinetobacter strains isolated from blood cultures
K. Kishii et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
A conjugative plasmid carrying the carbapenem resistance gene blaOXA-23 in AbaR4 in an extensively resistant GC1 Acinetobacter baumannii isolate
Mohammad Hamidian et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Rapid identification of Acinetobacter baumannii, Acinetobacter nosocomialis and Acinetobacter pittii with a multiplex PCR assay
Te-Li Chen et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2014)
OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii
Paul G. Higgins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Emergence of Carbapenem-Resistant Non-baumannii Species of Acinetobacter Harboring a blaOXA-51-Like Gene That Is Intrinsic to A. baumannii
Yi-Tzu Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years
Young Kyoung Park et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway
Nabil Karah et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
AbaR4 replaces AbaR3 in a carbapenem-resistant Acinetobacter baumannii isolate belonging to global clone 1 from an Australian hospital
Mohammad Hamidian et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Contribution of a Plasmid-Borne blaOXA-58 Gene with Its Hybrid Promoter Provided by IS1006 and an ISAba3-Like Element to β-Lactam Resistance in Acinetobacter Genomic Species 13TU
Te-Li Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Emergence and Distribution of Plasmids Bearing the blaOXA-51-Like Gene with an Upstream ISAba1 in Carbapenem-Resistant Acinetobacter baumannii Isolates in Taiwan
Te-Li Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
First Identification of blaOXA-51-like in Non-baumannii Acinetobacter spp.
Yi-Tzu Lee et al.
JOURNAL OF CHEMOTHERAPY (2009)
Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii
Te-Li Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species
Jane F. Turton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species
B La Scola et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
L. Poirel et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent Oxyrase to standardize the test method
PA Bradford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Share Paper
